- EN
- EMCDDA >
- Data >
- Statistical archive >
- Statistical bulletin 2012 >
- Data >
- tditab18d
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2010 or most recent year available
Part (iv) All inpatient clients by primary drug and frequency of use (%)
| Primary drug | Not used in the past month/occasional | Once a week or less | 2–6 times per week | Daily | Frequency known (n) | Frequency unknown | |
|---|---|---|---|---|---|---|---|
| Opioids | 14.5 | 5.9 | 14.6 | 65.0 | 9674 | 872 | |
| Cocaine | 24.0 | 7.8 | 23.8 | 44.5 | 1010 | 232 | |
| Stimulants | 23.6 | 10.9 | 30.2 | 35.3 | 3234 | 251 | |
| Cannabis | 13.1 | 9.4 | 20.4 | 57.1 | 2924 | 421 |
Notes:
Percentages are of clients whose frequency of use is known (n)
Only countries reporting data related to primary drug have been included.
The following countries have been included:BE, BG, CZ, DK, IE, GR, FR, CY, LU, HU, NL, AT, RO, SK, FI, SE, HR, TR
See also Table TDI-112 for distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — TDI table — inpatient treatment centres.
About the EMCDDA
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>
Contact us
EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11
Quick links
- Home
- Data
Drug-related data at your fingertips
Monitoring and analysing the nature and scale of the drugs phenomenon in Europe is a central part of the EMCDDA's work. The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent data on the drug situation in Europe. Access data »
- Countries
Drug-related information by country
The countries section makes it easier than ever to find drug-related information and data by country. Each page brings together all of our available products by topic or format for the country in question. Countries »
- Topics (A–Z)
New drugs and trends
Health consequences
Prevalence and epidemiology
Drug-related thematic pages
Drugs and society
Science and research
Best practice
- Best practice in prevention
- Best practice in treatment
- Best practice in harm reduction
- Best practice in social reintegration
- Standards and guidelines
- Exchange on Drug Demand Reduction Action (EDDRA)
- Evaluation Instruments Bank (EIB)
Health and social responses
Policy and law
Availability and supply
Drug profiles
Drug profiles are scientifically sound descriptions of drugs.
- Publications
Publications database
Our publications are tailored to the needs of specific audiences and published in a variety of print or web formats. Access the Publications database.
Search
Series/type
Annual report | Drugnet Europe | Drug policy profiles | Drugs in focus | Implementation reports | Insights | Joint publications | Joint reports | Literature reviews | Manuals | Monographs | National reports | Risk assessments | Selected issues | Technical data sheets | Thematic papers
Documents about the EMCDDA
Annual accounts | Brochures | Budget | General report of activities | Work programmes
Annual report: the state of the drugs problem in Europe
The annual report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field. It is available for download in PDF in 22 languages. - News and events
Media support
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:
Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 21 813 1711
Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 21 813 1711
- About the EMCDDA
Quick links (A-Z)
calls for tender | data protection | EMCDDA Director | EMCDDA units | faq | founding regulation | Management Board | national focal points | partners | Scientific Committee | staff list | vacancies
Page last updated: Monday, 09 July 2012